• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/21

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

21 Cards in this Set

  • Front
  • Back

Manipulation of Autonomic Synapse

-Presynaptic neuron (synthesis/storage/release)


-Postsynapthic (signal detection/action of cell activity)

Neurtransmission Pharmacologic Targets

-Block synthesis/storage: rate limiting (long term effects


-Block release: (rapid and effective action)


-Block reuptake: Increase synaptic transmitter conc. (selective/nonselective)


-Metabolism interfere: Reversible/irreversible (increases transmitter conc.)


-Interfere with action: Receptor Ant/agonists (highly specific)

Define: Agonist/Antagonist

Agonist: Activates receptor


Antagonist: blocks receptor

Mode of Action of Ant/agonists


NOT THE SAME AS Ant/agonism

Direct acting: physically binds to target


Indirect acting: interacts with non target site

Indirect Agonist

Physostigmine


-ACH receptor effector


-Mediated through inhibition of cholinesterase


-Increases local ACH


-therefore agonist for ACH receptor

Acetylcholine

-Present in neuromuscular junction and CNS


-Synthesized in axon terminal


-Diffuses across synaptic cleft


-Choline + acetyl CoA (choline acetyl transferase) ---> Acetylcholine + CoA

Acetylcholine degradation

Acetylcholinesterase


(turnover time of 150 microseconds)


(post synaptic)

Cholinergic transmission

1.Precursor transport (rate limiting)[hemocholinium]


2. Synthesis


3. Storage (Vesamicol)


4. Release (botulinum toxin)


5a. receptor action (Antagonists: Atropine/succinylcholine/trimethaphan. Agonist: Carbachol/pilocarpine)


5b. Degradation by AchE. ACHE inhibitors: reversible: neostigmine. Irreversible: Organophosphate

Cholinergic receptors: Two for ACH


Nicotonic/Muscarinic

Nicotinic: Ion channels. Ionotropic


Muscarinic: G-protein. Metabotropic

Nicotinic receptors

-Found on motor end plates (somatic targets)


-All ganglionic neurons for both (para/sympathetic)

Major G-protein types

Gs: Activates adenylyl cyclase, increase cAMP


Gi: Inhibitis adenylyl cyclase, decrease cAMP


Gq: Activates phospholipase CB, increase IP3 levels and intracellular Ca+ levels

Nicotinic Receptors

Nn: Neuronal (fire)


Nm: Skeletal muscle (contract)


Both ligand gated ion channels


- 2 Ach binding is stimulatory

Muscarinic Receptors (Gq)

M1,3,5 --> activate Gq


M3: located on smooth muscle glands


(cause contration/secretion)

Muscarinic Receptor (Gi)

M2,4 --> Activate Gi --> inhibit Adenylate cyclase (increase K+ permeability)


M2: on heart, decrease activity

Adrenergic Transmission Drug intervention

1. Tyrosine (Metyrosine [inhibitory]) TH rate limiting


2. Dopa --> DA (reserpine [inhibit])


2. Vesicle DA--> NE (amphet/tyra/ephedrine [Stimulatory])


3.Release (Bretylium/guanethidine)


4. NE


5a. Receptor action (Antagonist: phentolamine/propranolol. Agonist: isoproterenol/albuterol)


5b. Reuptake (Cocaine/SSRI/TCA's (imipramine)

Adrenergic Receptors division:

a --> a1, a2


b --> b1,b2,3


GPCR

Alpha-1

Agonist: Contraction/Secretion


Works in: smooth mussle/blood vessels/glands

Alpha-2

Agonist: Release neurotransmitters


Mostly presynaptic


Increase K+ permeability

Beta-1

Agonist: Release PKA --> phosphorylate proteins


Heart: Increase Heart Rate/Force contraction


Kidney: Renin release

Beta-2

Agonist: Release PKA --> phosphorylate proteins


Smooth muscle: Relaxation


Liver: Glycogenolysis/gluconeogenesis

Beta-3

Agonist: Release PKA --> phosphorylate proteins


Adipose tissue: Lipolysis